
Endonovo Therapeutics (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical Therapy for the treatment of inflammatory conditions, cardiovascular diseases and central nervous system disorders. Endonovo's Electroceutical Thera... Endonovo Therapeutics (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical Therapy for the treatment of inflammatory conditions, cardiovascular diseases and central nervous system disorders. Endonovo's Electroceutical Therapy is FDA-Cleared for the palliative treatment of pain and post-surgical edema (swelling) and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Endonovo's Electroceutical Therapy has CMS National Coverage for the treatment of chronic wounds. The Company's current pipeline of clinical-stage Electroceutical Therapies targets cardiovascular diseases and central nervous system disorders, including ischemic heart disease, acute concussions, post-concussion syndrome, traumatic brain injury (TBI) and multiple sclerosis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0001 | 0.0003 | 0.0001 | 1423352 | 0.00023927 | CS |
4 | -5.0E-5 | -33.3333333333 | 0.00015 | 0.0003 | 0.0001 | 1791360 | 0.00020776 | CS |
12 | -0.00014 | -58.3333333333 | 0.00024 | 0.0003 | 0.0001 | 5531956 | 0.00020313 | CS |
26 | -0.0002 | -66.6666666667 | 0.0003 | 0.0004 | 0.0001 | 17778621 | 0.00023083 | CS |
52 | -0.0009 | -90 | 0.001 | 0.0019 | 0.0001 | 12627994 | 0.00033907 | CS |
156 | -0.0099 | -99 | 0.01 | 0.028 | 0.0001 | 4477067 | 0.00085054 | CS |
260 | -0.09865 | -99.8987341772 | 0.09875 | 0.1495 | 0.0001 | 2713771 | 0.00248175 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.